J H Ashton - Concepedia

Author

J H Ashton

The University of Texas Southwestern Medical Center

Also Known As

J Ashton, J H Ashton, J. Ashton, J. H. Ashton, Juliet Ashton, Juliet H. Ashton

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center University of Texas Health Science Center at Dallas Campbell Collaboration S.L. Raheja Hospital Southwestern Medical Center

About

J H Ashton is an author at The University of Texas Southwestern Medical Center specializing in medicine, physiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	21	2.2K
2	Health Sciences	7	7	681
3	Allergy	2	2	133
4	Natural Sciences	1	1	253
5	Public Health	1	1	52

J H Ashton

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Neutral metalloendopeptidase in human lung tissue and cultured cells. Alice Johnson, J H Ashton, Werner Schulz, PubMed Lung InflammationRedox BiologyOxidative StressInflammationAngiogenesis	1985	253
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. John F. Eidt, Paul Allison, Stephen Noble, Journal of Clinical Investigation Endothelial InjuryBiomedical EngineeringPlatelet AggregationThrombosisCoronary Artery Stenosis	1989	238
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Paolo Golino, J H Ashton, L. Maximilian Buja, Circulation Vascular DiseasePossible MediatorsThromboxane A2Biomedical EngineeringCyclic Flow Variations	1989	215
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. J H Ashton, Claude R. Benedict, C. Fitzgerald, Circulation Heart FailureCardiovascular DiseaseMedicineVascular PharmacologyPhysiology	1986	168
Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms James T. Willerson, William B. Campbell, Michael D. Winniford, The American Journal of Cardiology Vascular DiseaseCardiovascular DiseasePhysiologyCardiologyVascular Biology	1984	168
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Paolo Golino, J H Ashton, Pia Glas-Greenwalt, Circulation Coronary ThrombosisThromboxane A2PharmacotherapyPersistent OcclusionAcute Myocardial Infarction	1988	151
The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Larry R. Bush, W B Campbell, Karl B. Kern, Circulation Research Selective AlphaCardiovascular PharmacologyPharmacotherapyCardiovascular FunctionPlatelet Aggregation	1984	116
Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. J H Ashton, Martin L. Ogletree, I M Michel, Circulation Heart FailureCardiovascular PharmacologySerotonin Receptor StimulationPharmacotherapyCyclic Flow Variations	1987	94
Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. Paolo Golino, L. Maximilian Buja, J H Ashton, Circulation Txa2 Receptor AntagonistCoronary Artery DiseaseThrombosisCoronary Artery StenosisSerotonin Receptor Antagonists	1988	88
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. J H Ashton, Joy M. Schmitz, William B. Campbell, Circulation Research Cardiovascular PharmacologyPharmacotherapyCyclic Flow VariationsBlood FlowThrombosis	1986	88

Page 1